Magellan BioScience Group - About the company
Magellan BioScience Group is an acquired company based in Tampa (United States), founded in 1997 by Todd Daviau and John M. Cronan. It operates as a Discovering novel therapeutics through unique microbial and peptide research libraries. Magellan BioScience Group has raised $25K in funding. The company has 39 active competitors, including 3 that have exited. Its top competitors include companies like C2 Pharma, AnalytiCon Discovery and Germe.
Company Details
Discovering novel therapeutics through unique microbial and peptide research libraries. The company offers diverse research libraries with unique compounds to study for potential therapeutic applications. These libraries provide access to the chemical diversity of natural products, enhancing prospects for novel discoveries in drug discovery research. They specialize in microbial strains, including microbial endophytic strains, and offer a synthetic peptide library for high-throughput screening or high-content screening microarray assays. The company seeks partners to develop novel applications for its peptide library. This is a B2B model focused on research and development, offering specialized libraries for pharmaceutical and biotechnology companies.
- Website
- magellanbioscience.com
- Email ID
- *****@magellanbioscience.com
Key Metrics
Founded Year
1997
Location
Tampa, United States
Stage
Acquired
Total Funding
$25K in 2 rounds
Latest Funding Round
Ranked
6th among 39 active competitors
Employee Count
8 as on Mar 31, 2026
Exit Details
Acquired by Meridian Bioscience (Mar 24, 2016)
Legal entities associated with Magellan BioScience Group
Magellan BioScience Group is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Magellan Bioscience Group Inc CIN: 1558050 , United States, Active | $1 - $1M (As on Sep 17, 2012) | - | - |
Magellan BioScience Group's acquisition details
Magellan BioScience Group got acquired by Meridian Bioscience on Mar 24, 2016 at an acquisition amount of $*****.
Click here to take a look at Magellan BioScience Group's acquisition in detail
Sign up to download Magellan BioScience Group's company profile
Magellan BioScience Group's funding and investors
Magellan BioScience Group has raised a total funding of $25K over 2 rounds. Its first funding round was on Jul 06, 2007. Magellan BioScience Group has 2 institutional investors.
Here is the list of recent funding rounds of Magellan BioScience Group:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 17, 2012 | 3590546 | Unattributed | 1617879 | 4735915 | 4569912 | 3336277 |
Jul 06, 2007 | 9784101 | Grant (prize money) | 9627679 | 9590339 | 5573494 |
View details of Magellan BioScience Group's funding rounds and investors
Magellan BioScience Group's founders and board of directors
Founder? Claim ProfileThe founders of Magellan BioScience Group are Todd Daviau and John M. Cronan.
Here are the details of Magellan BioScience Group's key team members:
- Todd Daviau: Co-Founder & ex-CEO of Magellan BioScience Group. Contact Info: 1 email address
- John M. Cronan: Co-Founder & CEO of Magellan BioScience Group.
View details of Magellan BioScience Group's Founder profiles and Board Members
Magellan BioScience Group's employee count trend
Magellan BioScience Group has 8 employees as of Mar 26. Here is Magellan BioScience Group's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Magellan BioScience Group's Competitors and alternates
Top competitors of Magellan BioScience Group include C2 Pharma, AnalytiCon Discovery and Germe. Here is the list of Top 10 competitors of Magellan BioScience Group, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | C2 Pharma 2014, Luxembourg (Luxembourg), Unfunded | Offering APIs for the discovery and development of natural products | - | - | 43/100 |
2nd | AnalytiCon Discovery 2000, Potsdam (Germany), Acquired | Specializes in natural products chemistry | $3.04M | 41/100 | |
3rd | Contract research, development and manufacturing for pharma, agri, food, and chemicals industries | - | - | 27/100 | |
4th | Metagreen 2015, Los Angeles (United States), Deadpooled | Develops technologies to harness the compounds of natural production | $12.1M | 27/100 | |
5th | Venoms and toxins for drug discovery and high throughput screening applications | - | - | 26/100 | |
6th | Magellan BioScience Group 1997, Tampa (United States), Acquired | Discovering novel therapeutics through unique microbial and peptide research libraries | $25K | 28/100 | |
7th | Preclinical services for drug discovery from natural products | - | 24/100 | ||
8th | Venom product library, a product of Latoxan, which is engaged in venom and toxin production | - | - | 24/100 | |
9th | Alfa Biotech 2015, Hangzhou (China), Unfunded | Supplier of phytochemical standards and plant extracts | - | - | 24/100 |
10th | Camasy Biotechnology 2015, Jinan (China), Unfunded | Dietary supplements and pharmaceutical intermediates from natural products | - | - | 24/100 |
Looking for more details on Magellan BioScience Group's competitors? Click here to see the top ones
Magellan BioScience Group's Investments and acquisitions
Magellan BioScience Group has made no investments or acquisitions yet.
News related to Magellan BioScience Group
•
Are you a Founder ?
FAQs about Magellan BioScience Group
Explore our recently published companies
- Wise Accelerate - Hanoi based, 2021 founded, Unfunded company
- AblyCon Global - Bengaluru based, 2014 founded, Unfunded company
- Civoya - 2025 founded, Unfunded company
- A Innovative Food Products - Ahmedabad based, 2016 founded, Unfunded company
- The Hashtech - Houston based, 2024 founded, Unfunded company
- Overloop - Ditchling based, 2017 founded, Acquired company